![](/img/cover-not-exists.png)
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer
Merz, Valeria, Zecchetto, Camilla, Santoro, Raffaela, Simionato, Francesca, Sabbadini, Fabio, Mangiameli, Domenico, Piro, Geny, Cavaliere, Alessandro, Deiana, Michaela, Valenti, Maria Teresa, Bazan, DJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-20-0395
Date:
June, 2020
File:
PDF, 3.28 MB
2020